Formulation, Optimization and Evaluation of Eudragit RL 100 nanoparticles loaded with Quercetin for its Hypolipidemic action by using Animal Model
Article Sidebar
Main Article Content
Abstract
Quercetin, a potent pharmacological active phytocompound, plays a crucial role in drug therapy. However, its essential role is limited due to poor water solubility and low bioavailability. To overcome these limitations and enhance oral bioavailability, Quercetin loaded Eudragit nanoparticles were prepared using a single emulsification solvent evaporation method and optimized by applying Box-Behnken design. This study aimed to investigate the anti-hyperlipidemic potential of Quercetin in Triton WR-1339 induced hyperlipidemic rats.
Hyperlipidemia was induced in rats using Triton WR-1339, and the hypolipidemic potential of Quercetin was evaluated at doses of 50 and 100 mg/kg. The results revealed that Quercetin significantly (p ≤ 0.005) altered the serum levels of total cholesterol (TC), triglycerides (TG), low-density lipoprotein cholesterol, and high-density lipoprotein cholesterol, bringing them close to normal levels in Triton WR-1339 induced hyperlipidemic rats.
Furthermore, both doses of Quercetin (50 and 100 mg/kg) showed significant reductions in TC and TG levels when compared to the standard atorvastatin treatment. The novel formulation of Quercetin loaded Eudragit polymeric nanoparticles displayed remarkable potential as a green antihyperlipidemic agent.
These findings suggest that Quercetin loaded Eudragit nanoparticles can effectively mitigate hyperlipidemia and have the potential to be a promising therapeutic option for lipid disorders. The enhanced bioavailability and bioactivity of Quercetin delivered through this novel formulation open new possibilities for its clinical application in managing hyperlipidemia. Further research and clinical studies are warranted to explore its translational potential and wider applications in drug therapy
Downloads
Article Details
This work is licensed under a Creative Commons Attribution 4.0 International License.
References
Wu T-H, Yen F-L, Lin L-T, Tsai T-R, Lin C-C, Cham T-M. Preparation, physicochemical characterization, and antioxidant effects of quercetin nanoparticles. International journal of pharmaceutics. 2008;346(1-2):160-8.
Tran TH, Guo Y, Song D, Bruno RS, Lu X. Quercetin-containing self-nanoemulsifying drug delivery system for improving oral bioavailability. Journal of pharmaceutical sciences. 2014;103(3):840-52.
Singh V, Pandey H, Misra V, Tiwari V, Srivastava P, Singh D. Hypolipidemic effect of [6]-Gingerol-loaded Eudragit polymeric nanoparticles in high-fat diet-induced rats and Gamma scintigraphy evaluation of gastric-retention time. Journal of Applied Pharmaceutical Science. 2022;12(6):156-63.
Wang T, Liu L, Deng J, Jiang Y, Yan X, Liu W. Analysis of the mechanism of action of quercetin in the treatment of hyperlipidemia based on metabolomics and intestinal flora. Food & function. 2023;14(4):2112-27.
Pool H, Quintanar D, Figueroa JdD, H. Bechara JE, McClements DJ, Mendoza S. Polymeric nanoparticles as oral delivery systems for encapsulation and release of polyphenolic compounds: impact on quercetin antioxidant activity & bioaccessibility. Food Biophysics. 2012;7:276-88.
Jankovic A, Chaudhary G, Goia F. Designing the design of experiments (DOE)–An investigation on the influence of different factorial designs on the characterization of complex systems. Energy and Buildings. 2021;250:111298.
Wong KC, Woo KZ, Woo KH. Ishikawa diagram. Quality Improvement in Behavioral Health. 2016:119-32.
Vanaja K, Shobha Rani R. Design of experiments: concept and applications of Plackett Burman design. Clinical research and regulatory affairs. 2007;24(1):1-23.
Ranga S, Jaimini M, Sharma SK, Chauhan BS, Kumar A. A review on Design of Experiments (DOE). Int J Pharm Chem Sci. 2014;3(1):216-24.
Vardhan H, Mittal P, Adena SKR, Mishra B. Long-circulating polyhydroxybutyrate-co-hydroxyvalerate nanoparticles for tumor targeted docetaxel delivery: Formulation, optimization and in vitro characterization. European journal of pharmaceutical sciences. 2017;99:85-94.
Lee E, Shah D, Porteus M, Wright JF, Bacchetta R. Design of experiments as a decision tool for cell therapy manufacturing. Cytotherapy. 2022;24(6):590-6.
Bezerra MA, Santelli RE, Oliveira EP, Villar LS, Escaleira LA. Response surface methodology (RSM) as a tool for optimization in analytical chemistry. Talanta. 2008;76(5):965-77.
Anderson MJ, Whitcomb PJ. RSM simplified: optimizing processes using response surface methods for design of experiments: Productivity press; 2016.
Tscharnuter W. Photon correlation spectroscopy in particle sizing. Encyclopedia of analytical chemistry. 2000:5469-85.
Harde H, Das M, Jain S. Solid lipid nanoparticles: an oral bioavailability enhancer vehicle. Expert opinion on drug delivery. 2011;8(11):1407-24.
Clogston JD, Patri AK. Zeta potential measurement. Characterization of nanoparticles intended for drug delivery. 2011:63-70.
Sirisha V, D’Souza JS. Polysaccharide-based nanoparticles as drug delivery systems. Marine OMICS. 2016:663-702.
Mu L, Feng S-S. PLGA/TPGS nanoparticles for controlled release of paclitaxel: effects of the emulsifier and drug loading ratio. Pharmaceutical research. 2003;20:1864-72.
Das S, Chaudhury A. Recent advances in lipid nanoparticle formulations with solid matrix for oral drug delivery. AAPS PharmSciTech. 2011;12:62-76.
ur Rehman J, Ali I, Saifullah S, Ullah S, Imran M, Shah MR. Synthesis of quercetin based self-assembling supramolecular amphiphiles for amphotericin B delivery. Journal of Molecular Liquids. 2021;333:115941.
Costa P. An alternative method to the evaluation of similarity factor in dissolution testing. International journal of pharmaceutics. 2001;220(1-2):77-83.
Laracuente M-L, Marina HY, McHugh KJ. Zero-order drug delivery: State of the art and future prospects. Journal of Controlled Release. 2020;327:834-56.
Huang J, Wang Q, Chu L, Xia Q. Liposome-chitosan hydrogel bead delivery system for the encapsulation of linseed oil and quercetin: Preparation and in vitro characterization studies. Lwt. 2020;117:108615.
Gouda R, Baishya H, Qing Z. Application of mathematical models in drug release kinetics of carbidopa and levodopa ER tablets. J Dev Drugs. 2017;6(02):1-8.
Ni S, Hu C, Sun R, Zhao G, Xia Q. Nanoemulsions‐based delivery systems for encapsulation of quercetin: Preparation, characterization, and cytotoxicity studies. Journal of Food Process Engineering. 2017;40(2):e12374.
Waterman KC, Carella AJ, Gumkowski MJ, Lukulay P, MacDonald BC, Roy MC, et al. Improved protocol and data analysis for accelerated shelf-life estimation of solid dosage forms. Pharmaceutical research. 2007;24:780-90.
Irudayaraj SS, Sunil C, Duraipandiyan V, Ignacimuthu S. In vitro antioxidant and antihyperlipidemic activities of Toddalia asiatica (L) Lam. leaves in Triton WR-1339 and high fat diet induced hyperlipidemic rats. Food and chemical toxicology. 2013;60:135-40.
Sikarwar MS, Patil M. Antihyperlipidemic activity of Salacia chinensis root extracts in triton-induced and atherogenic diet-induced hyperlipidemic rats. Indian journal of pharmacology. 2012;44(1):88.
Rampado R, Peer D. Design of experiments in the optimization of nanoparticle-based drug delivery systems. Journal of Controlled Release. 2023;358:398-419.
Venugopal V, Kumar KJ, Muralidharan S, Parasuraman S, Raj PV, Kumar KV. Optimization and in-vivo evaluation of isradipine nanoparticles using Box-Behnken design surface response methodology. OpenNano. 2016;1:1-15.
Fujimoto T, Terauchi S-y, Umehara H, Kojima I, Henderson W. Sonochemical preparation of single-dispersion metal nanoparticles from metal salts. Chemistry of Materials. 2001;13(3):1057-60.
Rahman HS, Rasedee A, How CW, Abdul AB, Zeenathul NA, Othman HH, et al. Zerumbone-loaded nanostructured lipid carriers: preparation, characterization, and antileukemic effect. International Journal of Nanomedicine. 2013:2769-81.
Tefas LR, Tomuţă I, Achim M, Vlase L. Development and optimization of quercetin-loaded PLGA nanoparticles by experimental design. Clujul Medical. 2015;88(2):214.
Thabet Y, Elsabahy M, Eissa NG. Methods for preparation of niosomes: A focus on thin-film hydration method. Methods. 2022;199:9-15.
Hao J, Fang X, Zhou Y, Wang J, Guo F, Li F, et al. Development and optimization of solid lipid nanoparticle formulation for ophthalmic delivery of chloramphenicol using a Box-Behnken design. International journal of nanomedicine. 2011:683-92.
Zuleger S, Lippold BC. Polymer particle erosion controlling drug release. I. Factors influencing drug release and characterization of the release mechanism. International journal of pharmaceutics. 2001;217(1-2):139-52.
JuŸwiak S, Wójcicki J, Mokrzycki K, Marchlewicz M, Białecka M, Wenda-Różewicka L, et al. Effect of quercetin on experimental hyperlipidemia and atherosclerosis in rabbits. Pharmacol Rep. 2005;57(57):604-9.
Sahebkar A. Effects of quercetin supplementation on lipid profile: A systematic review and meta-analysis of randomized controlled trials. Critical reviews in food science and nutrition. 2017;57(4):666-76.
Tsunematsu H, Hifumi H, Kitamura R, Hirai D, Takeuchi M, Ohara M, et al. Analysis of available surface area can predict the long-term dissolution profile of tablets using short-term stability studies. International journal of pharmaceutics. 2020;586:119504.
Blessy M, Patel RD, Prajapati PN, Agrawal Y. Development of forced degradation and stability indicating studies of drugs—A review. Journal of pharmaceutical analysis. 2014;4(3):159-65.
Klick S, Muijselaar PG, Waterval J, Eichinger T, Korn C, Gerding TK, et al. Stress testing of drug substances and drug products. Pharm Technol. 2005;29(2):48-66.